화학요법 유발 말초 신경병증 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00028941
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 151
Buy Now

[연구보고서] 화학요법으로 인한 말초신경병증 시장 규모는 2021년 8억 1,348만 달러에서 2028년 11억 7,426만 달러로 성장할 것으로 예상된다. CAGR은  2021년부터 2028년까지 5.4%.

화학요법으로 인한 말초 신경병증은 항종양제에 의해 발생하는 가장 빈번한 부작용 중 하나입니다. 임상적으로는 다양한 강도와 지속 기간의 운동 및 자율 신경 변화를 동반할 수 있는 대부분 감각 신경병증입니다. 암 환자들 사이에서 유병률이 높기 때문에 화학요법으로 인한 말초 신경병증은 암 환자와 생존자 모두, 그리고 의료 서비스 제공자 모두에게 주요 문제가 됩니다. 특히 현재로서는 이를 예방할 수 있는 효과적인 단일 방법이 없기 때문입니다. 더욱이 이 증후군을 치료할 가능성은 제한적입니다.

전략적 통찰

이 보고서는 시장 동향을 강조하는 화학 요법 유발 말초 신경병증(CIPN) 시장에 대한 통찰력과 심층 분석을 제공합니다. 기술 발전 및 시장 역학. 또한 전 세계 주요 시장 플레이어의 경쟁 환경 분석을 제공합니다. 또한 이 보고서에는 코로나19 대유행이 모든 지역의 화학요법 유발 말초 신경병증 시장에 미치는 영향이 포함되어 있습니다. 전염병은 전 세계적으로 공중 보건 위기와 경제 위기를 초래했습니다. 팬데믹 이전부터 말초신경병증을 유발하는 화학요법의 글로벌 시장은 정기적인 암 검진, 상담, 치료로 인해 지속적으로 성장하고 있었습니다. 코로나19의 첫 번째 물결은 종양학 사례에 대한 상담, 후속 조치 및 검사를 방해했습니다. 더욱이, 코로나19 팬데믹 초기 단계의 임상시험 및 환자에 대한 약물 공급 중단은 화학요법 유발 말초 신경병증 시장의 가장 중요한 영역에 영향을 미쳤습니다. 코로나19의 신속한 치료에 초점이 맞춰지면서 다양한 질병에 대한 소홀함이 초래되었습니다. 또한, 암 발병 사례의 감소와 치료를 위한 화학 요법 세션의 감소로 인해 화학 요법으로 인한 말초 신경병증 진단 및 치료에 대한 수요가 감소했습니다.  

화학요법으로 인한 말초 신경병증 시장의 수익성이 높은 지역


시장 통찰력
암의 유병률 증가로 화학요법으로 인한 말초 신경병증 시장 성장 촉진
/h3>

암은 전 세계적으로 주요 사망 원인입니다. 세계보건기구(WHO)에 따르면, 암은 2019년 기준 전 세계 183개국에서 70세 이하 인구의 사망 원인 1위, 전 연령층에서는 4위 사망 원인으로 보고됐다. . 또한 2021년 3월 WHO가 발표한 데이터에 따르면 2020년에는 다양한 암 유형으로 인해 최대 1,000만 명이 사망했습니다.

세계에서 가장 널리 퍼진 암, 2020

암 발병률이 증가함에 따라 전 세계 의료 시스템에 부담이 가중되고 화학 요법에 대한 수요도 늘어나고 있습니다. 화학요법으로 인한 말초 신경병증은 백금 유도체 약물(시스플라틴 및 옥살리플라틴), 방추사 독물[탁산(파클리탁셀 및 도세탁셀), 빈카 알칼로이드, 빈크리스틴, 에포틸론 및 에리불린], 보르테조밉, 그리고 탈리도마이드. 화학요법으로 인한 말초 신경병증의 높은 유병률은 암 환자와 생존자, 그리고 그들의 의료 서비스 제공자에 대한 우려를 불러일으킵니다. 특히 이 질환을 예방할 수 있는 효과적인 단일 방법이 없기 때문입니다.

“The 국제 통증 연구 협회 저널,” 항암화학요법으로 인한 말초신경병증 유병률은 항암치료 후 첫 달에 측정했을 때 68.1%(57.7~78.4), 3개월에 측정했을 때 60.0%(36.4~81.6), 6개월에 30.0%(6.4~53.5)로 보고됐다. 따라서 암 유병률이 증가하고 화학요법으로 인한 말초 신경병증의 발생률이 증가하면서 화학요법으로 인한 말초 신경병증 시장의 성장이 촉진됩니다.

약물 등급 기반 통찰력

< p>화학요법 유발 말초신경병증 시장은 약물군을 기준으로 스테로이드제, 항우울제, 항경련제, 마약제로 분류되며, 2021년에는 스테로이드 부문이 시장 점유율 1위를 차지했으며, 항경련 부문도 등록될 것으로 예상된다. 예측 기간 동안 가장 빠른 CAGR 6.2% 

화학요법으로 인한 말초 신경병증 시장, 제품별(2020년 및 2028년)

유통 채널 기반 통찰

화학요법으로 인한 말초 신경병증 시장은 유통 채널을 기준으로 병원 약국, 소매 약국, 온라인 약국으로 분류됩니다. 2021년에는 병원 약국 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한, 소매 약국 부문은 2021~2028년 동안 5.9%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.

화학요법 유발 말초 신경병증(CIPN) 시장 참여자는 제품 출시 및 확장과 같은 유기적 전략을 채택하는 데 중점을 둡니다. 증가하는 수요를 충족할 뿐만 아니라 전 세계적으로 입지와 제품 포트폴리오를 확장합니다.

지역별

지역을 기준으로 화학 요법으로 인한 말초 신경병증 시장은 북미(미국)로 분류됩니다. , 캐나다 및 멕시코), 유럽(영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽 지역), 아시아 태평양(중국, 일본, 인도, 호주, 한국 및 기타 아시아 태평양 지역), 중동 및 ; 아프리카(UAE, 사우디아라비아, 남아프리카공화국, 기타 중동 및 아프리카), 남부 및 아프리카 중미(브라질, 아르헨티나, 중남미 나머지 지역).

회사 프로필

  • Regenacy Pharmaceuticals, Inc.
  • Asahi Kasei Pharma Corporation
  • Novaremed
  • Makscientific, Llc
  • Wex Pharmaceuticals Inc.
  • Sova Pharmaceuticals, Inc.
  • Kineta, Inc.
  • Aptinyx Inc.
  • Apexian Pharmaceuticals, Inc.
  • Winsantor, Inc.    
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the chemotherapy induced peripheral neuropathy market?

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effects caused by antineoplastic agents. Clinically, CIPN is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes of varying intensity and duration. Due to its high prevalence among cancer patients, CIPN constitutes a major problem for both cancer patients and survivors as well as for their health care providers, especially because, at the moment, there is no single effective method of preventing CIPN; moreover, the possibilities of treating this syndrome are very limited.

What are the driving factors for the chemotherapy induced peripheral neuropathy market across the country?

The factors that are driving and restraining factors that will affect the chemotherapy induced peripheral neuropathy market in the coming years. Major factors driving the market growth include the increasing prevalence of cancer and increasing preference for chemotherapy. Additionally, the growing clinical trials for chemotherapeutic drugs is likely to emerge as a significant future trend in the market during the forecast period. However, lack of consolidated guidelines for chemotherapy hamper the chemotherapy induced peripheral neuropathy market growth.

Which segment is dominating the chemotherapy induced peripheral neuropathy market?

The chemotherapy induced peripheral neuropathy market, by drug class, is bifurcated into steroids, antidepressants, anti-seizure medicines, and narcotics. In 2021, the steroids segment held the largest share of the market. The anti-seizure medicines segment of the chemotherapy induced peripheral neuropathy market is expected to witness growth in its demand at the fastest CAGR during the forecast period.

Who are the major players in market the chemotherapy induced peripheral neuropathy market?

The chemotherapy induced peripheral neuropathy market majorly consists of the players such as Regenacy Pharmaceuticals, Inc, Asahi Kasei Pharma Corporation., Novaremed, Makscientific, Llc, Wex Pharmaceuticals Inc., Sova Pharmaceuticals, Inc., Kineta, Inc., Aptinyx Inc., Apexian Pharmaceuticals, Inc., and Winsantor, Inc. amongst others.

The List of Companies - Chemotherapy Induced Peripheral Neuropathy Market

  1. REGENACY PHARMACEUTICALS, INC
  2. ASAHI KASEI PHARMA CORPORATION
  3. NOVAREMED
  4. MAKSCIENTIFIC, LLC
  5. WEX PHARMACEUTICALS INC
  6. SOVA PHARMACEUTICALS, INC
  7. KINETA, INC.
  8. APTINYX INC.
  9. APEXIAN PHARMACEUTICALS, INC.
  10. WINSANTOR, INC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports